Skip to main content
Log in

14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Beaudry P, Cohen P, Brandel JP, et al. (1999) 14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 10:40–46

    Article  CAS  PubMed  Google Scholar 

  2. Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD (2000) Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48:893–901

    Article  CAS  PubMed  Google Scholar 

  3. Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF (2001) CSF detection of the 14-3-3 protein in unselected patients with dementia.Neurology 56:1528–1533

    Article  CAS  PubMed  Google Scholar 

  4. Fu H, Subramanian R, Masters S (2000) 14-3-3 proteins: structure, function and regulation.Annu Rev Pharmacol Toxicol 40:617–647

    Article  CAS  PubMed  Google Scholar 

  5. Irani DN, Kerr DA (2000) 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 355:901

    Article  CAS  PubMed  Google Scholar 

  6. Kurtzke J (1983) Rating neurologic impairment in multiple sclerosis.Neurology 33:1444–1452

    Article  CAS  PubMed  Google Scholar 

  7. Lublin FD, Reingold SC, for the National Multiple Sclerosis Society (1996) Defining the clinical course of multiple sclerosis: results of an international survey.Neurology 46:907–911

    Article  CAS  PubMed  Google Scholar 

  8. Martinez-Yélamos A, Saiz A, Sanchez-Valle R et al. (2001) 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis.Neurology 57:722–724

    Article  PubMed  Google Scholar 

  9. Poser CM, Paty DW, Scheinberg L, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols.Ann Neurol 13:227–231

    Article  CAS  PubMed  Google Scholar 

  10. Saiz A, Graus F, Dalmau J, Pifarre A, Marin C, Tolosa E (1999) Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders.Ann Neurol 46:774–777

    Article  CAS  Google Scholar 

  11. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278–285

    Article  CAS  PubMed  Google Scholar 

  12. Zerr I, Pocchiari M, Collins S, et al. (2000) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.Neurology 55:811–815

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jérôme de Seze.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Seze, J., Peoc’h, K., Ferriby, D. et al. 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis. J Neurol 249, 626–627 (2002). https://doi.org/10.1007/s004150200074

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004150200074

Keywords

Navigation